Aldeyra Therapeutics, Inc. (ALDX) stock
ALDXNasdaqPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 6/30
$0.67−0.02 (-3.29%)
Close on Nov 18, 2026Market cap $40.49MP/E –Yield –
Aldeyra Therapeutics pe ratio
The price-to-earnings ratio is the share price divided by diluted earnings per share over the trailing twelve months.
Aldeyra Therapeutics's pe ratio was 10.3× on Jan 30, 2015.
PE Ratio at the end of each year
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| 2015 | Jan 30, 2015 | 10.3× | +4.1 |
| 2014 | Dec 31, 2014 | 6.1× | – |
See a number that looks wrong?